Contact
Please use this form to send email to PR contact of this press release:
Alessa Therapeutics Announces First Australian Patient Enrolled in Biolen-PC Study for New Therapy for Prostate Cancer
TO:
Timothy Hay
synthesis media llc
+1 510-593-0285